A patient self-assessment software combining compliance protocols to improve prescriber confidence, reduce liability, and improve patient outcomes.

患者自我评估软件结合了依从性协议，可提高处方者的信心、减少责任并改善患者的治疗结果。

• 批准号: 10013399
• 负责人: ABRAHAM G HARTZEMA
• 金额: $ 72.23万
• 依托单位: CLARITY, LLC
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-08-01 至 2022-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10013399
• 关键词: Activities of Daily Living; Alternative Therapies; Benefits and Risks; Caring; Chronic; Clinic; Clinical; Computer software; Computerized Medical Record; Continuity of Patient Care; Control Groups; Dangerousness; Data; Dependence; Devices; Documentation; Electronic Health Record; Environment; Epidemic; Evaluation; Exposure to; Fentanyl; Fright; Future; Goals; Health Technology; Internet; Intervention; Knowledge; Laws; Legal; Measures; Medical; Monitor; Morphine; Online Systems; Opioid; Outcome; Outcomes Research; Overdose; Pain; Pain management; Patient Care; Patient risk; Patient-Focused Outcomes; Patients; Pharmaceutical Preparations; Pharmacologic Substance; Phase; Physical Function; Physicians; Play; Policies; Primary Health Care; Probability; Protocol Compliance; Protocols documentation; Provider; Reporting; Research; Research Personnel; Risk; Risk Factors; Role; Self Assessment; Standardization; Technical Expertise; Time; Training; Visit; Withdrawal; addiction; care systems; commercialization; dashboard; design; digital; experience; help-seeking behavior; high risk; improved; milligram; mortality; non-cancer pain; novel; opioid epidemic; opioid misuse; opioid overdose; opioid therapy; overdose death; patient population; patient safety; prescription opioid; programs; public health relevance; software development; substance misuse; synthetic opioid; tool; willingness

PROJECT ABSTRACT The current overdose epidemic is being fueled by widespread, non-medical use of opioids prescribed by mostly well-meaning physicians with inadequate training on how to properly initiate, monitor and discontinue opioid therapy. Many patients being initiated on chronic opioid therapy have factors putting them at higher risk for substance misuse and possible future overdose, however the typical primary care visit for a new patient is too short for a thorough evaluation. This puts patients at risk by perpetuating a substandard level of care, and puts prescribers at risk by lacking substantiated documentation to support the legal standard “legitimate medical purpose”. Most current measures aimed at solving the opioid epidemic have not considered the biggest obstacle to appropriate patient care and good medicolegal documentation, which is time. To complicate the matter, many physicians are simply refusing to prescribe opioids for fear of criminal, civil or regulatory intervention. This is compounding the issue by inundating clinics that do prescribe opioids with new, unverified patients that are often almost out of medication or already in withdrawal. This common scenario is contributing to the steady rise of fentanyl and other synthetic opioid related overdose deaths by pushing patients with pain, dependence and addiction to seek help through illegal means. The Care Continuity Program (CCP), a product of Sure Med Compliance, is a novel, online patient self-assessment used by prescribers of opioids to better identify patient risk factors and therapy benefit. This tool is completed by the patient, outside of the office, using an internet enabled device and follows a compliance driven protocol developed by analyzing case law against physicians in mis-prescribing opioid cases. Results, in the form of a date and time stamped legal report, are instantly transmitted to the prescriber’s electronic health records, mitigating the prescriber’s civil and criminal risk. A brief of findings is displayed within the software through a dashboard and on the summary page of the report. This software offering includes a mobile and standard web-based application. The objective of the proposed research is to validate the protocols and delivery system of the CCP by measuring patient outcomes, prescriber confidence, and completeness of documentation in the patient chart in primary care and pain management settings, pre and post implementation of the CCP.

项目摘要 阿片类药物的广泛非医疗使用正在助长目前的过量流行病 开处方的大多是善意的医生，他们没有受过如何正确 启动、监测和停止阿片类药物治疗。许多患者开始接受慢性阿片类药物治疗 治疗有因素使他们在药物滥用和可能的未来更高的风险 然而，对于一个新病人来说，典型的初级保健就诊时间太短，无法进行全面的评估。 这使病人处于危险之中，因为长期存在不合格的护理水平，并使处方医生处于危险之中，因为缺乏 证明文件，以支持法律的标准“合法的医疗目的”。最新措施 旨在解决阿片类药物流行病没有考虑到适当的病人护理的最大障碍， 好的法医学文件也就是时间使问题复杂化的是，许多医生只是拒绝 因为害怕刑事、民事或监管干预而开阿片类药物。这使问题更加复杂， 那些开阿片类药物的诊所充斥着新的、未经证实的病人，这些病人往往几乎没有药物可吃。 或者已经戒断了这种常见的情况有助于芬太尼和其他合成药物的稳步上升。 阿片类药物相关的过量死亡，通过推动疼痛，依赖和成瘾患者寻求帮助， 非法手段。护理连续性计划（CCP）是Sure Med合规性的一个产品，是一个新颖的在线患者 阿片类药物处方者使用的自我评估，以更好地识别患者风险因素和治疗获益。此工具 由患者在办公室外使用支持互联网的设备完成， 通过分析针对医生错误处方阿片类药物病例的案例法制定的驱动协议。结果，在 日期和时间戳的法律的报告的形式，被立即传输到开处方者的电子健康 记录，减轻开处方者的民事和刑事风险。软件中显示了调查结果摘要 通过仪表板和报告的摘要页面。此软件产品包括一个移动的和 标准的基于Web的应用程序。拟议研究的目标是验证协议和交付 通过测量患者结局、处方者信心和文件完整性， 在初级保健和疼痛管理环境中的患者图表中，CCP实施前后。